Durante, Cosimo

Type 2 deiodinase polymorphism (threonine 92 alanine) predicts L-thyroxine dose to achieve target thyrotropin levels in thyroidectomized patients

Torlontano, M., Durante, C., Torrente, I., Crocetti, U., Augello, G., Ronga, G., Montesano, T., Travascio, L., Verrienti, A., Bruno, R., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism

Thyroid Disorders and TreatmentsThyroid Cancer Diagnosis and Treatment

Cited by 92

Cancer Care During COVID-19 Era: The Quality of Life of Patients With Thyroid Malignancies

Falcone, R., Grani, G., Ramundo, V., Melcarne, R., Giacomelli, L., Filetti, S., & Durante, C. (2020) · Frontiers in Oncology

COVID-19 and Mental HealthCOVID-19 and healthcare impacts

Cited by 42

Therapy of diabetes and dyslipidemia in acromegaly.

Tamburrano, G., Durante, C., & Baldelli, R. (2002) · Pituitary

Pituitary Gland Disorders and TreatmentsGrowth Hormone and Insulin-like Growth Factors

Cited by 9